#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type V Rectal cancer Uveal melanoma Urethral valves Neuroblastoma Cardiac arrest Fungal infection Autoimmune disorder HER2 mutant non-small cell lung cancer Brain abscess Pseudomyxoma peritonei Acute on chronic liver failure Factor IX deficiency Liver abscess Vulval cancer recurrent More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Trials in Disease Rhabdoid tumour – Trials in Disease Cystic fibrosis – Diagnostics Factor IX deficiency – Diagnostics Carcinoid syndrome – Life with Disease Mucopolysaccharidosis I – Trials in Disease Hairy cell leukaemia – Life with Disease Mantle cell lymphoma stage II – Trials in Disease Fragile X syndrome – Treatment Atypical haemolytic uraemic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azd0901 Sufentanil Citrate Magnesium Sulfate Heptahydrate Prucalopride Tigecycline Fremanezumab Cipepofol Neostigmine Methylsulfate Nipocalimab Interferon Beta-1B Oxazepam SAROGLITAZAR HEMIMAGNESIUM ABBV-CLS-628 68Ganota-Anti-Her2 Vhh1 Lovastatin GAXILOSE Pyrazinamide Telitacicept Selatogrel Poa Pratensis More therapies…

    Learn about Your Condition

    Tendon disorder Malignant fibrous histiocytoma Agitation postoperative CDKL5 deficiency disorder IgA nephropathy Mucosal inflammation Postoperative delirium Neurogenic bladder Biliary tract operation Breast cancer metastatic Alopecia areata Small intestine carcinoma Synovitis Arterial stiffness Craniopharyngioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Switching from Intravenous to Oral Antibiotics in Patients with Infective Endocarditis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Benzylpenicillin Sodium
    • Clavulanic Acid
    Belgium

  • A Study Testing SUL-238 in Patients with Early, Untreated Parkinson’s Disease to Assess Effects on Brain Energy Metabolism

    Recruiting

    2 1
    The Netherlands

  • A Study Testing TUB-040 Combined with Standard Cancer Drugs for Patients with High-Grade Epithelial Serous or Endometrioid Ovarian Cancer

    Recruiting

    1 1 1
    Investigated Drugs:
    • Tub-040
    Belgium

  • A Study Using [AL[18F]F]FAPI-74 PET Scan to Improve Diagnosis and Monitoring of Giant Cell Arteritis in Patients with This Blood Vessel Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    • Giant cell arteritis
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Belgium

  • A Study Comparing Gadopiclenol and Gadoterate Meglumine for Heart MRI Scans in Children with Congenital Heart Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Meglumine Gadoterate
    Spain

  • A study testing semaglutide with counselling to reduce cravings and use of chemsex-related drugs in adults who use these substances

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Semaglutide
    Belgium
Previous Page
1 … 74 75 76 77 78 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!